Migraine and adiponectin: Is there a connection?

Cephalalgia

Volumn 27, Issue 5, 2007, Pages 435-446

  Peterlin, B L ^a   Bigal, M E ^b,c   Tepper, S J ^b,d   Urakaze, M ^e   Sheftell, F D ^b,f   Rapoport, A M ^b,g  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b NEW ENGLAND CENTER FOR HEADACHE   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF TOYAMA   (Japan)

^f NEW YORK MEDICAL COLLEGE   (United States)

^g Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

Adiponectin; Cytokines; Headache; Migraine

Indexed keywords

ADIPONECTIN; ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; C REACTIVE PROTEIN; CYTOKINE; GLYCERYL TRINITRATE; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; NITRIC OXIDE; PROLACTIN; ROSIGLITAZONE; SEX HORMONE; SUMATRIPTAN; TOPIRAMATE; TUMOR NECROSIS FACTOR ALPHA;

ATHEROGENESIS; CIRCADIAN RHYTHM; DIABETES MELLITUS; HEADACHE; HUMAN; MIGRAINE; NONHUMAN; OBESITY; REVIEW; THYROID DISEASE;

ADIPONECTIN; ADIPOSE TISSUE; BRAIN; CYTOKINES; HUMANS; MALE; MIGRAINE DISORDERS; MODELS, IMMUNOLOGICAL; MODELS, NEUROLOGICAL; STATISTICS;

EID: 34247501822     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2007.01306.x     Document Type: Review

References (87)

1. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American migraine study II. Headache 2001 41: 646 57.
2. Goadsby PJ. Migraine pathophysiology. Headache 2005 45 (Suppl. 1 S14 S24.
3. Moskowitz MA. Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. Trends Pharmacol Sci 1992 13: 307 11.
4. Johnson KW, Bolay H. Neurogenic inflammatory mechanisms. In: Olesen J, Goadsby PJ, Ramadan NM, Tfelt-Hansen P, Welch KMA. editors. The headaches, 3rd edn. Philadelphia: Lipincott Williams & Wilkins 2006: 309 19.
5. Sheftell F, Rapoport A, Weeks R, Walker B, Gammerman I, Baskin S. Montelukast in the prophylaxis of migraine: a potential role for leukotriene modifiers. Headache 2000 40: 158 63.
6. Touyz RM. Endothelial cell IL-8, a new target for adiponectin: implications in vascular protection. Circ Res 2005 97: 1216 9.
7. Trujillo ME, Scherer PE. Adiponectin - journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med 2005 257: 167 75.
8. Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocrine Rev 2005 26: 439 51.
9. Kobashi C, Urakaze M, Kishida M, Kibayashi E, Kobayashi H, Kihara S, et al. Adiponectin inhibits endothelial synthesis of interleukin-8. Circ Res 2005 97: 1245 52.
10. Tsao TS, Lodish HF, Fruebis J. ACRP30, a new hormone controlling fat and glucose metabolism. Eur J Pharmacol 2002 440: 213 21.
11. Xu A, Chan KW, Hoo RL, Wang Y, Tan KC, Zhang J, et al. Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes. J Biol Chem 2005 280: 18073 80.
12. Waki H, Yamauchi T, Kamon J, Ito Y, Uchida S, Kita S, et al. Impaired multimerization of human adiponectin mutants associated with diabetes. J Biol Chem 2003 278: 40352 63.
13. Tsao TS, Tomas E, Murrey HE, Hug C, Lee DH, Ruderman NB, et al. Role of disulfide bonds in Acrp30/Adiponectin structure and signaling specificity: different oligomers activate different signal transduction pathways. J Biol Chem 2003 278: 50810 7.
14. Kobayashi H, Ouchi N, Kihara S, Walsh K, Kumada M, Abe Y, et al. Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ Res 2004 94: e27 e31.
15. Pajvani UB, Hawkins M, Combs TP, Rajala MW, Doebber T, Berger JP, et al. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem 2004 279: 12152 62.
16. Neumeier M, Weigert J, Schaffler A, Wehrwein G, Muller-Ladner U, Scholmerich J, et al. Different effects of adiponectin isoforms in human monocytic cells. J Leukocyte Biol 2006 79: 803 8.
17. Tsatsanis C, Zacharioudaki V, Androulidaki A, Dermitzaki E, Charalampopoulos I, Minas V, et al. Adiponectin induces TNF-α and IL-6 in macrophages and promotes tolerance to its self and other pro-inflammatory stimuli. Biochem Biophys Res Commum 2005 335: 1254 63.
18. Spranger J, Verma S, Gohring I, Bobbert T, Seifert J, Sindler AL, et al. Adiponectin does not cross the blood-brain barrier but modifies cytokine expression of brain endothelial cells. Diabetes 2006 55: 141 7.
19. Wolf AM, Wolf D, Rumpold H, Enrich B, Tilg H. Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem Biophys Res Commun 2004 323: 630 5.
20. Ouchi N, Kihara S, Funahashi T, Matsuzawa Y, Walsh K. Obesity, adiponectin and vascular inflammatory disease. Current Opin Lipidol 2003 14: 561 6.
21. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, et al. Paradoxical decrease of an adipose-specific protein, adiponectin in obesity. Biochem Biophys Res Commun 1999 257: 79 83.
22. Qi Y, Takahashi N, Hileman SM, Patel HR, Berg AH, Pajvani UB, et al. Adiponectin acts in the brain to decrease weight. Nat Med 2004 10: 524 9.
23. Pan W, Tu H, Kastin AJ. Differential BBB interactions of three ingestive peptides: obestatin, ghrelin, and adiponectin Peptides 2006 27: 911 6.
24. Wang Y, Xu A, Knight C, Xu LY, Cooper GJ. Hydroxylation and glycosylation of the four conserved lysine residues in the collagenous domain of adiponectin. J Biol Chem 2002 277: 19521 9.
25. Peake PW, Kriketos AD, Campbell LV, Shen Y, Charlesworth JA. The metabolism of isoforms of human adiponectin: studies in human subjects and in experimental animals. Eur J Endocrinol 2005 153: 409 17.
26. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005 115: 911 9.
27. Waeber C. Prostanoids and other inflammatory mediators. In: Olesen J, Goadsby PJ, Ramadan NM, Tfelt-Hansen P, Welch KMA, editors. The headaches, 3rd edn. Philadelphia: Lippincott Williams & Wilkins 2006: 175 81.
28. Masaki T, Chiba S, Tatsukawa H, Yasuda T, Noguchi H, Seike M, et al. Adiponectin protects LPS-induced liver injury thorugh modulation of TNF-alpha in KK-Ay obese mice. Hepatology 2004 40: 177 84.
29. Fernandez-Real JM, Ricar W. Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 2003 24: 278 301.
30. Klein J, Perwitz N, Kraus D, Fasshauer M. Adipose tissue as source and target for novel therapies. Trends Endocrinol Metabolism 2006 17: 26 32.
31. Blake GJ, Ridker PM. Novel clinical markers of vascular wall inflammation. Circ Res 2001 89: 763 71.
32. Sarchielli P, Alberti A, Baldi A, Coppola F, Rossi C, Pierguidi L, et al. Proinflammatory cytokines, adhesion molecules, and lymphocyte integrin expression in the internal jugular blood of migraine patients without aura assessed ictally. Headache 2006 46: 200 7.
33. Empl M, Sostak P, Riedel M, Schwarz M, Schwarz M, Muller N, Forderreuther S, et al. Decreased sTNF-RI in migraine patients? Cephalalgia 2003 23: 55 8.
34. Goadsby PJ, Edvinsson L. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 1993 33: 48 56.
35. Frangogiannis NG. Chemokines in the ischemic myocardium: from inflammation to fibrosis. Inflamm Res 2004 53: 585 95.
36. Scher AI, Terwindt GM, Picavet HSJ, Verschuren WM, Ferrari MD, Launer LJ. Cardiovascular risk factors and migraine: the GEM population-based study. Neurology 2005 64: 614 20.
37. Donaghy M, Chang CL, Pulter N. Duration, frequency, recency, and type of migraine and the risk of ischaemic stroke in women of childbearing age. J Neurol Neurosurg Psychiatry 2002 73: 747 50.
38. Del Prete G, De Carli M, Almerigogna F, Giudizi MG, Biagiotti R, Romagnani S. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 1993 150: 353 60.
39. Munno I, Marinaro M, Bassi A, Cassiano MA, Causarano V, Centonze V. Immunological aspects in migraine: increase of IL-10 plasma levels during attack. Headache 2001 41: 764 7.
40. Goldstein BJ, Scali R. Adiponectin: a novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab 2004 89: 2563 8.
41. Olesen J, Iversen HK, Thomsen LL. Nitric oxide supersensitivity: a possible molecular mechanism of migraine pain. Neuroreport 1993 4: 1027 30.
42. Lassen LH, Ashina M, Christiansen I, Ulrich V, Grover R, Donaldson J, et al. Nitric oxide synthase inhibition: a new principle in the treatment of migraine attacks. Cephalalgia 1998 18: 27 32.
43. Iversen HU, Reuter U. Nitric oxide involvement in migraines. In: Olesen J, Goadsby PJ, Ramadan NM, Tfelt-Hansen P, Welch KMA, editors. The headaches, 3rd edn. Philadelphia: Lippincott Williams & Wilkins 2006: 281 7.
44. Reuter U, Bolay H, Jansen-Olesen I, Chiarugi A, Sanchez del Rio M, Letourneau R, et al. Delayed inflammation in rat meninges: implications for migraine pathophysiology. Brain 2001 124: 2490 502.
45. Kruuse C, Thomsen LL, Birk S, Olesen J. Migraine can be induced by sildenafil without changes in middle cerebral artery diameter. Brain 2003 126: 241 7.
46. Levy D, Strassman A. Modulation of dural nociceptor mechanosensitivity by the nitric oxide-cyclic GMP signaling cascade. J Neurophysiol 2004 92: 766 72.
47. Fumeron F, Aubert R, Siddiq A, Betoulle D, Pean F, Hadjadj S, et al. Adiponectin gene polymorphisms and adiponectin levels are independently associated with the development of hyperglycemia during a 3-year period: the epidemiologic data on the insulin resistance syndrome prospective study. Diabetes 2004 53: 1150 7.
48. Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003 423: 762 9.
49. Ducros A, Joutel A, Vahedi K, Cecillon M, Ferreira A, Bernard E, et al. Mapping of a second locus for familial hemiplegic migraine to 1q21-q23 and evidence of further heterogeneity. Ann Neurol 1997 42: 885 90.
50. McCarthy LC, Hosford DA, Riley JH, Bird MI, White NJ, Hewett DR, et al. Single-nucleotide polymorphism alleles in the insulin receptor gene are associated with typical migraine. Genomics 2001 78: 135 49.
51. Split W, Szydlowska M. Headaches in non insulin-dependent diabetes mellitus. Funct Neurol 1997 12: 327 32.
52. Nilsson L, Binart N, Bohlooly YM, Bramnert M, Egecioglu E, Kindblom J, et al. Prolactin and growth hormone regulate adiponectin secretion and receptor expression in adipose tissue. Biochem Biophys Res Commun 2005 331: 1120 6.
53. Papakostas Y, Daras M, Markianos M, Stefanis C. Increased prolactin response to thyrotropin releasing hormone during migraine attacks. J Neurol Neurosurg Psychiatry 1987 50: 927 8.
54. Murialdo G, Martignoni E, DeMaria A, Bonura ML, Sances G, Bono G, et al. Changes in the dopaminergic control of prolactin secretion and in ovarian steroids in migraine. Cephalalgia 1986 6: 43 9.
55. Awaki E, Takeshima T, Takahashi K. A neuroendocrinological study in female migraineurs: prolactin and thyroid stimulating hormone responses. Cephalalgia 1989 9: 187 93.
56. Klimek A. Growth hormone and prolactin release in migraine patients. In: Pfaffenrath V, Lundberg PO, Sjaastad O, editors. Updating in headache. New York: Springer-Verlag 1983: 241 8.
57. Nattero G, Corno M, Savi L, Isaia GC, Priolo C, Mussetta M. Prolactin and migraine: effect of L-dopa on plasma prolactin levels in migraineurs and normals. Headache 1986 26: 9 12.
58. Silberstein S, Merriam G. Sex hormones and headache 1999. Neurology 1999 53 (S1 S3 S13.
59. Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States. Relation to age, income, race and other sociodemographic factors. JAMA 1992 267: 64 9.
60. Kudrow L. Plasma testosterone levels in cluster headache: preliminary results. Headache 1976 16: 28 31.
61. Romitti A, Martelletti P, Gallo MF, Glacovazzo M. Low plasma testosterone levels in cluster headache. Cephalalgia 1983 3: 41 4.
62. Stillman MJ. Testosterone replacement therapy for treatment refractory cluster headache. Headache 2006 46: 925 33.
63. Combs TP, Berg AH, Rajala MW, Kleoanov S, Iyengar P, Jimenez-Chillaron JC, et al. Sexual differentiation, pregnancy, caloric restriction, and aging affect the adipocyte-specific secretory protein adiponectin. Diabetes 2003 52: 268 76.
64. Somerville BW. The role of estradiol withdrawal in the etiology of menstrual migraine. Neurology 1972 22: 355 65.
65. Silberstein S, Merriam G. Sex hormones and headache (menstrual migraine). Neurology 1999 53 (Suppl. 1 S3 13.
66. Yaturu S, Prado S, Grimes SR. Changes in adipocyte hormones leptin, resistin, and adiponectin in thyroid dysfunction. J Cell Biochem 2004 277: 29359 62.
67. Bigal ME, Sheftell FD, Rapoport AM, Tepper SJ, Lipton RB. Chronic daily headache: identification of factors associated with induction and transformation. Headache 2002 42: 575 81.
68. Matsubara M, Namioka K, Katayose S. Decreased plasma adiponectin concentrations in women with low-grade C-reactive protein elevation. Eur J Endocrinol 2003 148: 657 62.
69. Ouchi N, Kihara S, Funahashi T, Nakamura T, Nishida M, Kumada M, et al. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 2003 107: 671 468.
70. Welch KMA, Brandes AW, Salerno L, Brandes JL. C-reactive protein may be increased in migraine patients who present with complex clinical features. Headache 2006 46: 197 969.
71. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000 20: 1595 9.
72. Scher AI, Stewart WF, Ricci JA, Lipton RB. Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 2003 106: 81 8.
73. Bigal ME, Liberman JN, Lipton RB. Obesity and migraine: a population study. Neurology 2006 66: 545 50.
74. Bigal ME, Gironda M, Tepper SJ, Feleppa M, Rapoport AM, Sheftell FD, et al. Headache prevention outcome and body mass index. Cephalalgia 2006 26: 445 50.
75. Rainero I, Limone P, Ferrero M, Valfre W, Pelissetto C, Rubino E, et al. Insulin sensitivity is impaired in patients with migraine. Cephalalgia 2005 25: 593 7.
76. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE. The adipocyte-secreted protein ACRP30 enhances hepatic insulin action. Nat Med 2001 7: 947 53.
77. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999 100: 2473 6.
78. Ouchi N, Kihara S, Arita Y, Nishida M, Matsuyama A, Okamoto Y, et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 2001 103: 1057 63.
79. Yamauchi T, Kamon J, Waki H, Tereuchi Y, Kubota N, Hara K, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001 7: 941 6.
80. Bic Z, Blix GG, Hopp HP, Leslie FM, Schell MJ. The influence of a low-fat diet on incidence and severity of migraine headaches. J Women's Health Gender-Based Med 1999 8: 623 30.
81. Dzielinska Z, Januszewicz A, Wiecek A, Demkow M, Makowiecka-Ciela M, Prejbisz A, et al. Decreased plasma concentration of a novel anti-inflammatory protein - adiponectin - in hypertensive men with coronary artery disease. Thrombosis Res 2003 110: 365 9.
82. Tietjen GE. The relationship of migraine and stroke. Neuroepidemiology 2000 19: 13 9.
83. Tzourio C, Kittner SJ, Bousser MG, Alperovitch A. Migraine and stroke in young women. Cephalalgia 2000 20: 190 9.
84. Bousser MG, Welch MA. Relation between migraine and stroke. Lancet Neurol 2005 4: 533 42.
85. Bluher M, Fasshauer M, Kralisch S, Schon MR, Krohn K, Paschke R. Regulation of adiponectin receptor R1 and R2 gene expression in adipocytes of C57BL/6 mice. Biochem Biophys Res Commun 2005 329: 1127 32.
86. Russell D. Cluster headache: severity and temporal profiles of attacks and patient activity prior to and during attacks. Cephalalgia 1981 1: 209 16.
87. Peres MF, Zuckerman E, da Cunha Tanuri F, Moreira FR. Melatonin, 3 mg, is effective for migraine prevention. Neurology 2004 63: 757.